Name: Very good according to the company’s financial health.
Item: INTERNIS PHARMACEUTICALS LIMITED
Rating: 4
Author: CheckTheCopmany

INTERNIS PHARMACEUTICALS

Phone: +44 (0)1484 842 217

B⁺ rating

ABOUT INTERNIS PHARMACEUTICALS LIMITED

Our mission

To become the UK’s fastest growing specialty pharmaceutical company. To build the Internis brand as the UK’s leading bone health experts with dedicated quality, safety education and patient care programmes.

Founded in 2010, Internis is a UK speciality pharmaceutical company engaged in the development and commercialisation of highly effective and innovative medicines currently aimed at the treatment and prevention of a range of common bone disorders, such as osteoporosis and vitamin D3 deficiency.

Internis has grown rapidly in the past 4 years since commercialising their first product Accrete-D3. It is positioned now as one of the UK’s fastest growing pharmaceutical companies and is still expanding, by focusing on niche branded products where there is an unmet medical need.

STADA is a pan-European pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. With sales of over two billion Euros, STADA affords Thornton & Ross with both research and development support and financial investment.

Thornton & Ross has become the Centre of Excellence within the STADA group in order to promote the development of OTC and Dermatology business.

An essential factor for the continued success of STADA’s business model is its individual market focus through the international network of local marketing and sales companies. In order to rapidly adapt to individual country healthcare market changes, STADA’s local sales companies retain a high level of autonomy, allowing the flexibility to adapt and capitalise on local country market opportunities.

Internis Pharmaceuticals Ltd. is wholly owned by Thornton & Ross/ Stada. With the support of the parent company Thornton & Ross there is an appetite to continue to invest in growth in both market portfolio and new product development and acquisition.

Helping Improve the UK's Bone Health

Working with Healthcare Professionals and Patient Groups to Deliver Products required for Better Bone Health

KEY FINANCES

Year

2012

Assets

£1023.66k ^{▲ £874.3k (585.40 %)}

Cash

£23.88k ^{▼ £-0.57k (-2.32 %)}

Liabilities

£1162.76k ^{▲ £879.23k (310.10 %)}

Net Worth

£-139.11k ^{▲ £-4.93k (3.67 %)}

Download Balance Sheet for 2011-2012

REGISTRATION INFO

Company name: INTERNIS PHARMACEUTICALS LIMITED
Company number: 07162670
Status: Active
Categroy: Private Limited Company
Date of Incorporation: 19 Feb 2010
Age - 16 years
Home Country: United Kingdom

CONTACTS

Website: www.internispharma.co.uk
Phones: +44 (0)1484 842 217
+44 (0)1484 847 301
08708 510 207
01484 842 217
01484 847 301
Registered Address: LINTHWAITE,
HUDDERSFIELD,
WEST YORKSHIRE,
HD7 5QH

ECONOMIC ACTIVITIES

86900: Other human health activities

LAST EVENTS

08 Nov 2016: Appointment of Mr Barry Draude as a director on 31 October 2016
29 Sep 2016: Full accounts made up to 31 December 2015
13 May 2016: Appointment of Mr Geoffrey Martin Adams as a secretary on 1 May 2016

CHARGES

16 July 2013
Status: Satisfied on 13 January 2015
Delivered: 20 July 2013
Persons entitled: Norgine B.V.
Description: 'Fultium' trademark reg no UK00002564136 and 'accrete'…

24 September 2012
Status: Satisfied on 30 April 2014
Delivered: 25 September 2012
Persons entitled: Conance Limited
Description: Fixed and floating charge over the undertaking and all…

3 May 2012
Status: Satisfied on 18 July 2013
Delivered: 10 May 2012
Persons entitled: National Westminster Bank PLC
Description: Fixed and floating charge over the undertaking and all…